MET vs UTHR · P/E 13, rev $38.23B vs P/E 20, rev $1.56B
MetLife Inc (MET) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
MET currently screens at market cap $52.16B and trailing P/E 12.7. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the MET and UTHR stock pages for the full models.
Not investment advice.